Heba S. A. Elzahabi - Concepedia

Author

Heba S. A. Elzahabi

Also Known As

Bshra A. Alsfouk, El-Zahabi, Heba S.A., El‐Zahabi, Heba S. A., Heba Elzahabi, Heba S. A. Elzahabi, Heba S. A. El‐Zahabi, Heba S. Elzahabi, Heba S.A. El-Zahabi, Heba S.A. El-zahabi, Heba S.A. ElZahabi

Publications

Citations

H-Index

Concepts

All Affiliations

Al-Azhar University Cairo University National Research Centre Almaarefa University Alfaisal University

About

Heba S. A. Elzahabi is an author at Al-Azhar University specializing in pharmacology, medicine, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	12	14	621
2	Natural Sciences	9	9	376
3	Biochemistry	7	7	206
4	Biomolecular Engineering	5	5	242
5	Engineering	1	1	136

Heba S. A. Elzahabi

Publications

997

Citations

H-Index

Page 1

	Year	Citations
Synthesis of some new pyrazole-based 1,3-thiazoles and 1,3,4-thiadiazoles as anticancer agents Kamal M. Dawood, Taha M. A. Eldebss, Heba S. A. Elzahabi, European Journal of Medicinal Chemistry Medicinal ChemistryEngineeringMedicineDrug DiscoveryOrganic Chemistry	2013	136
Synthesis and antiviral activity of some new bis-1,3-thiazole derivatives Kamal M. Dawood, Taha M. A. Eldebss, Heba S. A. Elzahabi, European Journal of Medicinal Chemistry Medicinal ChemistryNatural SciencesMedicineNew Bis-1,3-thiazole DerivativesChemistry	2015	109
Microwave-assisted synthesis and in-vitro anti-tumor activity of 1,3,4-triaryl-5-N-arylpyrazole-carboxamides Hatem A. Abdel‐Aziz, Heba S. A. Elzahabi, Kamal M. Dawood European Journal of Medicinal Chemistry Medicinal ChemistryOrganic ChemistryAnti-cancer AgentPharmacologyMicrowave-assisted Synthesis	2010	88
Anticancer evaluation and molecular modeling of multi-targeted kinase inhibitors based pyrido[2,3-<i>d</i>]pyrimidine scaffold Heba S. A. Elzahabi, Eman S. Nossier, Nagy M. Khalifa, Journal of Enzyme Inhibition and Medicinal Chemistry	2018	72
Discovery of new quinolines as potent colchicine binding site inhibitors: design, synthesis, docking studies, and anti-proliferative evaluation Mohamed Hagras, Moshira A. El Deeb, Heba S. A. Elzahabi, Journal of Enzyme Inhibition and Medicinal Chemistry	2021	70
Facile Synthesis and <i>In‐Vitro </i>Antitumor Activity of Some Pyrazolo[3,4‐<i>b</i>]pyridines and Pyrazolo[1,5‐<i>a</i>]pyrimidines Linked to a Thiazolo[3,2‐<i>a</i>]benzimidazole Moiety Hatem A. Abdel‐Aziz, Tamer S. Saleh, Heba S. A. Elzahabi Archiv der Pharmazie Combinatorial ChemistryMedicinal ChemistryBiochemistryMedicineDrug Discovery	2009	68
Synthesis, characterization of some benzazoles bearing pyridine moiety: Search for novel anticancer agents Heba S. A. Elzahabi European Journal of Medicinal Chemistry Medicinal ChemistryNovel Anticancer AgentsHeterocyclicNatural SciencesMedicine	2011	61
Design, synthesis and evaluation of new quinazolin-4-one derivatives as apoptotic enhancers and autophagy inhibitors with potent antitumor activity Heba S. A. Elzahabi, Mohamed S. Nafie, Dina A. Osman, European Journal of Medicinal Chemistry Medicinal ChemistryAutophagy InhibitorsMedicinePotent Antitumor ActivityPharmacological Agent	2021	58
Design, synthesis, and anti-cancer evaluation of new pyrido[2,3-d]pyrimidin-4(3H)-one derivatives as potential EGFRWT and EGFRT790M inhibitors and apoptosis inducers Heba S. A. Elzahabi, Eman S. Nossier, Rania A. Alasfoury, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	42
Discovery of new 1 <i>H</i> -pyrazolo[3,4- <i>d</i> ]pyrimidine derivatives as anticancer agents targeting EGFR <sup>WT</sup> and EGFR <sup>T790M</sup> Ahmed A. Abdel Gaber, Mohamed Sobhy, Abdallah Turky, Journal of Enzyme Inhibition and Medicinal Chemistry	2022	39

Page 1